Within B-ALL, the role of FLT3, KRAS and NRAS mutations has been investigated mostly in the pediatric setting and has been linked to hyperdiploid, MLL-rearranged ALL, hypodiploid, as well as high-risk pediatric cases, as elucidated by NGS [26, 30-36]. Here, KMT2A is linked to acute lymphoblastic leukemia.